Filter announcements
Loading...
Founded in 2019, Asston Pharmaceuticals Limited manufactures and exports pharmaceutical formulations and nutraceuticals under the "Asston" brand, utilizing a diversified business model that includes direct sales, contract manufacturing, and export primarily to African markets.
7th Annual Report of Asston Pharmaceuticals Limited for the Financial Year 2025-26.
Notice of 7th Annual General Meeting scheduled to be held on 29th September, 2026 at 12:30 P.M.
Allotment of 24,10,431 equity shares via Preferential Allotment
Fixing 29th September, 2026, as the date for convening the 7th Annual General Meeting of the Company.
Voting Result and Scrutinizer report for EGM held on 31st July, 2026 through VC-OAVM